Stocks and Investing Stocks and Investing
Thu, August 11, 2022

Matthew Harrison Maintained (ZNTL) at Buy with Decreased Target to $60 on, Aug 11th, 2022


Published on 2024-10-27 22:36:23 - WOPRAI, Matthew Harrison
  Print publication without navigation


Matthew Harrison of Morgan Stanley, Maintained "Zentalis Pharmaceuticals, Inc." (ZNTL) at Buy with Decreased Target from $95 to $60 on, Aug 11th, 2022.

Matthew has made no other calls on ZNTL in the last 4 months.



There are 5 other peers that have a rating on ZNTL. Out of the 5 peers that are also analyzing ZNTL, 0 agree with Matthew's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Matthew


  • Andrew Berens of "SVB Leerink" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 10th, 2022
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $55 on, Wednesday, August 10th, 2022
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Decreased Target to $70 on, Friday, July 29th, 2022
  • Tyler Van Buren of "Cowen & Co." Initiated at Buy on, Tuesday, July 12th, 2022
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Decreased Target to $85 on, Tuesday, April 12th, 2022
Contributing Sources